Colon Cancer Biomarkers: Implications for Personalized Medicine

The heterogeneity of colon cancers and their reactions presents both a challenge and promise for personalized medicine. The challenge is to develop effective biologically personalized therapeutics guided by predictive and prognostic biomarkers. Presently, there are several classes of candidate bioma...

Descripción completa

Detalles Bibliográficos
Autor principal: Pritzker, Kenneth P.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711712/
https://www.ncbi.nlm.nih.gov/pubmed/33066312
http://dx.doi.org/10.3390/jpm10040167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711712/
https://www.ncbi.nlm.nih.gov/pubmed/33066312
http://dx.doi.org/10.3390/jpm10040167

Ejemplares similares